UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 673

Sortiert nach

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

The New England journal of medicine, 2016-11, Vol.375 (19), p.1856-1867

2016

Link zum Volltext

Verfügbarkeit prüfen

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

Clinical cancer research, 2015-02, Vol.21 (3), p.632-641

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3120-3125

2011

Link zum Volltext

Verfügbarkeit prüfen

New Radiotherapy and Chemoradiotherapy Approaches for Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-03, Vol.31 (8), p.1029-1038

2013

Link zum Volltext

Verfügbarkeit prüfen

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Clinical cancer research, 2015-02, Vol.21 (4), p.870-881

2015

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5043-5051

2008

Link zum Volltext

Verfügbarkeit prüfen

Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology

Nature communications, 2022-11, Vol.13 (1), p.6572-6572, Article 6572

2022

Link zum Volltext

Verfügbarkeit prüfen

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

Scientific reports, 2021-10, Vol.11 (1), p.20059-20059, Article 20059

2021

Link zum Volltext

Verfügbarkeit prüfen

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4708-4713

2008

Link zum Volltext

Verfügbarkeit prüfen

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

Clinical cancer research, 2015-12, Vol.21 (24), p.5439-5444

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2063-2069

2012

Link zum Volltext

Verfügbarkeit prüfen

Induction Chemotherapy for Head and Neck Cancer: Recent Data

The oncologist (Dayton, Ohio), 2010-10, Vol.15 (S3), p.3-7

Vokes, Everett E.

2010

Link zum Volltext

Verfügbarkeit prüfen

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-01, Vol.28 (1), p.56-62

2010

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Journal of clinical oncology, 2004-01, Vol.22 (1), p.77-85

2004

Link zum Volltext

Verfügbarkeit prüfen

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2509-2515

2012

Link zum Volltext

Verfügbarkeit prüfen

Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4740-4746

2010

Link zum Volltext

Verfügbarkeit prüfen

Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1698-1704

2007

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non–small-cell Lung Cancer

Clinical lung cancer, 2018-05, Vol.19 (3), p.230-238.e2

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1382-1388

2004

Link zum Volltext

Verfügbarkeit prüfen

The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.3021-3031

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression and mutational analysis of MET in human solid cancers

Genes chromosomes & cancer, 2008-12, Vol.47 (12), p.1025-1037

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5578-5587

2005

Link zum Volltext

Verfügbarkeit prüfen

2022 Presidential Address: Advancing Equitable Cancer Care Through Innovation

Journal of clinical oncology, 2022-09, Vol.40 (25), p.2859-2862

Vokes, Everett E.

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 673

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(622)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(669)
Japanisch
(99)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(440)
Science & Technology
(433)
Life Sciences & Biomedicine
(425)
Oncology
(381)
Female
(260)
Male
(258)
Middle Aged
(247)
Aged
(237)
Biological And Medical Sciences
(208)
Medical Sciences
(207)
Adult
(202)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(146)
Tumors
(128)
Combined Modality Therapy
(112)
Lung Neoplasms - Drug Therapy
(109)
Aged, 80 And Over
(108)
Head And Neck Neoplasms - Drug Therapy
(108)
Chemotherapy
(107)
Treatment Outcome
(101)
Pharmacology. Drug Treatments
(95)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(173)
Journal Of Thoracic Oncology
(58)
Cancer
(33)
Clinical Cancer Research
(32)
Lung Cancer
(29)
Clinical Lung Cancer
(19)
International Journal Of Radiation Oncology, Biology, Physics
(19)
Cancer Research
(18)
Seminars In Oncology
(18)
Investigational New Drugs
(16)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

New Radiotherapy and Chemoradiotherapy Approaches for Non–Small-Cell Lung Cancer

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology

Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Induction Chemotherapy for Head and Neck Cancer: Recent Data

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non–small-cell Lung Cancer

Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan

The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Expression and mutational analysis of MET in human solid cancers

Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

2022 Presidential Address: Advancing Equitable Cancer Care Through Innovation

Suchergebnisse filtern